Funding Announcements

"The response to AcuPebble SA100 since its launch has been incredible, and we are thrilled to see the product being used to help patients and clinicians in the real world. This funding will help us reach our initial goal of diagnosing one million patients and gives us the opportunity to continue working on new products that will fundamentally improve the lives of millions of people living with severe chronic conditions."

"We were hugely impressed by the drive and ambition of the Currensea team, who have created the UK’s first direct debit travel card. It is exciting to be backing such a forward-thinking firm. The Currensea team has already built an impressive business and we’re delighted to be supporting their growth ambitions."

"I’m very proud of our team in completing this successful financing round, marking a significant step in Doccla’s vision of making virtual wards a core part of modern healthcare systems. From the company’s beginnings in 2019, we have continued to grow and expand and have received contract extensions from all of our clients, proving the inherent value of Doccla to the healthcare sector. Combining new technology with a service layer and clinical capacity reduces work for the NHS. We look forward to using this new level of support to further build on our success by getting more hospitals on board and developing our technology and clinical capacity to help solve the hospital bed crisis and alleviate the immense pressures on the NHS and other healthcare systems."

"To have raised the largest Series A round in the digital ad fraud space to date is a strong validation of the fraud prevention platform we have developed and its success,"